Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.
-
Upload
vincent-rodgers -
Category
Documents
-
view
222 -
download
5
Transcript of Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.
![Page 1: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/1.jpg)
Cystic Fibrosis Patient: Lily Johnson
Case study by Alexa Angelo
![Page 2: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/2.jpg)
Lily Johnson• 14 year old Caucasian female• Diagnosed with Cystic Fibrosis
when she was 6 months old• Very active girl and participates in
dance class three times a week and runs cross country for her high school (usually 5 to 7 miles a day, 3 to 4 days per week)
• Hospitalized because she caught a cold that her medications could not cure; may have pneumonia
Click icon to add picture
![Page 3: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/3.jpg)
What is Cystic Fibrosis?
![Page 4: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/4.jpg)
What is Cystic Fibrosis? (1)
Caused by a mutation of the cystic fibrosis transmembrane conductance regulator (CFTR)
The abnormal mutation of CFTR causes thick viscous mucous secretions that eventually lead to obstruction of the glands and ducts of various organ systems, including the respiratory tract, the gastrointestinal tract, the liver, the genitourinary system, and the sweat glands.
![Page 5: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/5.jpg)
Signs and Symptoms?
![Page 6: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/6.jpg)
Symptoms of Cystic Fibrosis (2)In
new
born
s • Delayed growth
• Failure to gain weight normally
• No bowel movements within first 48 hours of life
• Salty tasting skin
Gast
roin
test
inal • Severe
constipation
• Increased gas
• Bloating• Nausea or
loss of appetite
• Stools that contain fat
Resp
irato
ry • Coughing• Increased
mucus in lungs and sinuses
• Fatigue• Nasal
congestion• Recurring
pneumonia
![Page 7: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/7.jpg)
Diagnosis (2)
Tests include:
• Sweat chloride test
• Blood test to confirm mutation of CFTR gene
• Sputum cultures to test for any infections typical to CF
• Pancreatic function tests
• Pulmonary function tests
• DNA-based test to detect genetic variation that causes CF
![Page 8: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/8.jpg)
Treatment for CF (2)
Antibiotics
Inhaled medicines
DNAase enzyme therapy
High concentration of salt solutions
Flu and PPV vaccines annually
Possible lung transplant
Oxygen therapy
Percussion nest, manual chest percussion, A-capella, and TheraPEP device
![Page 9: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/9.jpg)
Possible Nutrition Therapy goals?
![Page 10: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/10.jpg)
Medical Nutrition Therapy (1) Lily has a very low BMI of 17, and is a very active child
This shows her increase for energy requirements : RDA 110% to 150% for a steady weight gain
Fat consumption is increased (35% to 40% total Kcal)
Protein consumption (15% to 20% total Kcal)
CHO needs to be distributed evenly throughout the day to prevent CHO loading because CF patients are more likely to develop Type 2 DM
Administer Multivitamin with the following vitamin amounts:
Age Vitamin A (IU)
Vitamin E (IU)
Vitamin D (IU)
Vitamin K (IU)
>8 10,000 200-400 400-800 0.3-0.5
![Page 11: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/11.jpg)
Specific Macronutrient Goals for Lily
Total energy requirements: 3,000 kcal
FAT: 3,000 x .40 = 1,200 kcal from fat
1,200/9 = 133 g fat/day
Protein: 3,000 x .15 = 450 kcal from protein
450/ 4 = 113 g protein/day
CHO: 3,000 x .45= 1,350 kcal/day
1,350/4 = 338 g CHO/day
![Page 12: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/12.jpg)
Overall Plan of Action
Increase Lily’s energy intake by adding additional kcal in the form of in-between meal snacks with nutrient-dense foods particularly high in fats
Fortified beverages or pudding may be beneficial
Vitamin supplementation for the following nutrients: Vitamins A, D, E and K, iron and zinc
Monitor weight and lab values
Make sure diet is high in salt, because CF patients are at risk for hyponatremia
![Page 13: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/13.jpg)
Prognosis (2)
Most children with CF live fairly healthy lives until they reach adulthood.
The lung disease eventually worsens until they are disabled
A person with CF has an average life span to approximately 37 years
Death is usually caused by lung complications
![Page 14: Cystic Fibrosis Patient: Lily Johnson Case study by Alexa Angelo.](https://reader036.fdocuments.us/reader036/viewer/2022082413/56649da05503460f94a8b69c/html5/thumbnails/14.jpg)
References
1. Nelms, M. N. (2011). Nutrition therapy and pathophysiology (2nd ed.). Belmont, CA: Wadsworth, Cengage Learning.
2. Cystic fibrosis - PubMed Health. National Center for Biotechnology Information. Retrieved November 10, 2012, from http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001167/
3. http://www.medicine.virginia.edu/clinical/departments/medicine/divisions/digestive-health/nutrition-support-team/nutrition-articles/GoodinArticle.pdf
4. http://www.mayoclinic.com/health/cystic-fibrosis/DS00287/DSECTION=treatments-and-drugs
5. http://www.lung.org/assets/documents/publications/solddc-chapters/cf.pdf